Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
22%
OVERLAP
BY WEIGHT
21
# OF OVERLAPPING
HOLDINGS
HRTS
44
HOLDINGS
48%
ALSO IN IBB
IBB
249
HOLDINGS
10%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus IBB)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.3% | 7.8% | 3.3% |
|
VERTEX PHARMACEUTICALS INC | 2.5% | 7.7% | 2.5% |
|
ALNYLAM PHARMACEUTICALS INC | 2.4% | 5.7% | 2.4% |
|
AMGEN INC | 2.3% | 7.4% | 2.3% |
|
REGENERON PHARMACEUTICALS | 2.1% | 5.9% | 2.1% |
HRTS Overweight Relative to IBB
|
ELI LILLY & CO | 7.8% |
|
UNITEDHEALTH GROUP INC | 5.1% |
|
ABBOTT LABORATORIES | 4.6% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.1% |
 |
ASTRAZENECA PLC | 4.0% |
|
BOSTON SCIENTIFIC CORP | 3.8% |
|
ABBVIE INC | 3.7% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
 |
NOVO NORDISK A/S-B | 3.3% |
 |
MEDTRONIC PLC | 3.3% |
HRTS Underweight Relative to IBB
|
VERTEX PHARMACEUTICALS INC | -5.3% |
|
AMGEN INC | -5.2% |
|
GILEAD SCIENCES INC | -4.5% |
|
REGENERON PHARMACEUTICALS | -3.8% |
|
ALNYLAM PHARMACEUTICALS INC | -3.3% |
 |
ARGENX SE ADR | -3.1% |
|
IQVIA HOLDINGS INC | -3.1% |
|
METTLER-TOLEDO INTERNATIONAL | -2.5% |
|
NATERA INC | -2.2% |
|
BEIGENE LTD. SPONSORED ADR | -2.1% |